IBB is breaking out to the upside, with an initial target around $124, the 127.2% extension of the major swing from this year's high in January to the lows in April, followed by the 161.8% at $131.

I'm jumping in via September $125 calls.
biotechChart PatternsTechnical IndicatorsIWMNASDAQ 100 CFDQQQRUSSELL 2000SPX (S&P 500 Index)SPDR S&P 500 ETF (SPY) Trend AnalysisXLV

更多:

免責聲明